PatrickAFlumeMD
Pulmonology • Charleston, SCCritical Care Medicine, Pleural Disease
Professor, Medicine, Medical University of South Carolina College of Medicine
Dr. Flume is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Education & Training
University of North Carolina HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 1990 - 1993
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1987 - 1990- The University of Texas Health Science Center at San AntonioClass of 1987
Certifications & Licensure
SC State Medical License 1993 - 2025
NC State Medical License 1990 - 1998
TX State Medical License 1988 - 1992
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR Mutation Start of enrollment: 2009 Sep 01
- MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis Start of enrollment: 2010 Nov 04
- Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients Start of enrollment: 2011 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsTargeting neutrophil serine proteases in bronchiectasis.James D Chalmers, Marcus A Mall, Sanjay H Chotirmall, Anne E O'Donnell, Patrick A Flume
The European Respiratory Journal. 2024-11-21 - Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy.Raksha Jain, Giselle Peng, MinJae Lee, Ashley Keller, Sophia Cosmich
Chest. 2024-09-27 - 1 citationsThe impact of switching to race-neutral reference equations on FEVpercent predicted among people with cystic fibrosis.Margaret Rosenfeld, Elizabeth A Cromwell, Michael S Schechter, Clement Ren, Patrick A Flume
Journal of Cystic Fibrosis. 2024-05-01
Press Mentions
New Breakthrough Treatments for Cystic FibrosisJuly 30th, 2024- Refining Your Search: A Team Approach to Identifying Patient Cohorts Using Data from the Electronic Health RecordApril 12th, 2023
- A New Way to Improve Clinical Trial Enrollment and DiversityMarch 22nd, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
